✦ LIBER ✦

Clindamycin-primaquine versus pentamidine for the second-line treatment of pneumocystis pneumonia

✍ Scribed by Tark Kim; Sung-Han Kim; Ki-Ho Park; Oh Hyun Cho; Heungsup Sung; Mi-Na Kim; Sang-Ho Choi; Jin-Yong Jeong; Jun Hee Woo; Yang Soo Kim; Sang-Oh Lee

Book ID: 106287506
Publisher: Springer
Year: 2009
Tongue: English
Weight: 202 KB
Volume: 15
Category: Article
ISSN: 1341-321X
DOI: 10.1007/s10156-009-0710-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of Pentamidine Analogues as

Development of Pentamidine Analogues as New Agents for the Treatment of Pneumocystis carinii Pneumonia

✍ RICHARD R. TIDWELL; SUSAN K. JONES; J. DIETER GERATZ; KWASI A. OHEMENG; CONSTANC 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 821 KB

PCN23 COST-EFFECTIVENESS ANALYSIS OF LAP

PCN23 COST-EFFECTIVENESS ANALYSIS OF LAPATINIB PLUS CAPECITABINE VERSUS CAPECITABINE ALONE IN THE SECOND LINE TREATMENT FOR BREAST CANCER TREATMENT

✍ F Ejzykowicz; JW Hay 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

982 Cost-Effectiveness of First-Line Ver

982 Cost-Effectiveness of First-Line Versus Second-Line Telaprevir Combination Treatment in the Management of Chronic Hepatitis C Virus Infection for Treatment-NaïVE Patients With IL28B Genotype CC

✍ Anita Brogan; Sandra E. Talbird; James R. Thompson; Jeffrey D. Miller; Shelley G 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Cost-effectiveness analysis of pemetrexe

Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population

✍ Yumi Asukai; Amparo Valladares; Carlos Camps; Eifiona Wood; Kaisa Taipale; Jorge 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 781 KB

Randomized phase II study of three doses

Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer

✍ Christian Manegold, Johan Vansteenkiste, Felipe Cardenal, Wolfgang Schuette, Pen 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 250 KB

A randomized phase III study of the doce

A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer

✍ Athanasios G Pallis; Sophia Agelaki; Athina Agelidou; Ioannis Varthalitis; Kosta 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 359 KB